Abnormal Expression of WSB1 in Lung Adenocarcinoma: A Potential Prognostic and Immunotherapeutic Sensitivity Biomarker. AWMR [Internet]. 2025 Dec. 31 [cited 2026 Feb. 11];1(2):48-63. Available from: https://awmr.cscholar.com/article/view/1000360